Biotricity (BTCY)
(Real Time Quote from BATS)
$0.80 USD
-0.04 (-4.31%)
Updated Jul 23, 2024 03:53 PM ET
After-Market: $0.80 0.00 (0.00%) 4:12 PM ET
3-Hold of 5 3
D Value A Growth B Momentum A VGM
Balance Sheet
Fiscal Year End for Biotricity Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 1 | 12 | 2 | 1 |
Receivables | 1 | 1 | 2 | 2 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 2 | 1 | 0 | 0 |
Other Current Assets | 0 | 1 | 0 | 0 | 0 |
Total Current Assets | 4 | 5 | 15 | 4 | 2 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 6 | 7 | 17 | 4 | 2 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 10 | 5 | 3 | 3 | 2 |
Current Portion Long-Term Debt | 12 | 5 | 2 | 4 | 2 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 1 | 4 | 0 |
Total Current Liabilities | 23 | 11 | 5 | 10 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 11 | 13 | 12 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 0 | 0 | 1 |
Minority Interest (Liabilities) | 1 | 0 | 0 | 0 | 0 |
Total Liabilities | 37 | 26 | 19 | 11 | 5 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 96 | 93 | 92 | 56 | 44 |
Retained Earnings | -128 | -113 | -93 | -63 | -46 |
Other Equity | 0 | 0 | -1 | 0 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -31 | -20 | -2 | -7 | -3 |
Total Liabilities & Shareholder's Equity | 6 | 7 | 17 | 4 | 2 |
Total Common Equity | -31 | -20 | -2 | -7 | -3 |
Shares Outstanding | 9.40 | 8.70 | 8.50 | 6.50 | 6.00 |
Book Value Per Share | -3.35 | -2.28 | -0.25 | -1.05 | -0.50 |
Fiscal Year End for Biotricity Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 1 | 0 | 1 | 0 |
Receivables | NA | 1 | 2 | 2 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 2 | 2 | 2 | 2 |
Other Current Assets | NA | 0 | 0 | 0 | 1 |
Total Current Assets | NA | 4 | 4 | 5 | 4 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 6 | 5 | 7 | 6 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 10 | 8 | 7 | 7 |
Current Portion Long-Term Debt | NA | 12 | 10 | 8 | 6 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 1 | 3 | 2 |
Total Current Liabilities | NA | 23 | 19 | 18 | 15 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 11 | 11 | 12 | 13 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 1 | 1 | |
Minority Interest (Liabilities) | NA | 1 | 1 | 1 | 0 |
Total Liabilities | NA | 37 | 33 | 34 | 30 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 96 | 96 | 93 | 93 |
Retained Earnings | NA | -128 | -123 | -120 | -116 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -31 | -28 | -27 | -23 |
Total Liabilities & Shareholder's Equity | NA | 6 | 5 | 7 | 6 |
Total Common Equity | 0 | -31 | -28 | -27 | -23 |
Shares Outstanding | 21.60 | 9.40 | 9.40 | 8.50 | 8.70 |
Book Value Per Share | 0.00 | -3.35 | -2.95 | -3.14 | -2.69 |